未登录

Y

Yue Hu

University of Electronic Science and Technology of China

H指数:13

被引数:500

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MASLD and CMRFs: Combination or Separation? An Open Exploration From the Perspective of All-Cause Mortality

MASLD与CMRFs：合并还是分离？——基于全因死亡率的开放性探讨

Liver International

IF5.2

2025-07-010

PRE

Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies

白藜芦醇对青光眼视网膜损伤的保护作用：一项预临床研究的系统评价和Meta分析

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-01-150

OA

Letter to the Editor: Aspirin and GLP-1RAs-The missing confounders of empagliflozin for MASLD without diabetes mellitus?

IF15.8

2024-07-240

PRE

Letter to the Editor: New confounders emerging with new evidence regarding reduced HCC and improved survival

IF15.8

2024-06-051

OA

The vaccine-response in patients with cirrhosis after COVID-19 vaccination: A systematic analysis of 168,245 patients with cirrhosis

JOURNAL OF HEPATOLOGY

IF33

2023-10-012

PRE

Effect of Multi-Walled Carbon Nanotubes on the Carbon and Nitrogen Cycling Processes in Saline Soil

IF3.4

2023-09-220

OA

Letter to the Editor: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection?

IF15.8

2023-07-170

OA

Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations

IF15.8

2023-05-111

OA

More efforts to explore the association between cirrhosis and COVID-19 mortality, and the association between NAFLD and severe COVID-19

JOURNAL OF HEPATOLOGY

IF33

2023-05-010

OAAI

Meta-analysis of Partial Breast Irradiation

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-03-011

PRE

Letter regarding The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial

RADIOTHERAPY AND ONCOLOGY

IF5.3

2023-01-010

OAAI

Meta-analysis of Low-Dose Irradiation for COVID-19

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-01-011

OAAI

Letter regarding Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials

RADIOTHERAPY AND ONCOLOGY

IF5.3

2022-12-010

PRE

Novel grading system for ischemia-reperfusion injury manifestations in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

SCIENTIFIC REPORTS

IF3.9

2022-11-116

OAAI

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-145

OAAI

Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer

右、左侧结直肠癌免疫相关因子的差异表达及预后相关性研究

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-227

OAAI

Identification of Novel Phenotypes Correlated with CKD: A Phenotype-Wide Association Study

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2022-01-011

OAAI

Lipocalin-2 Variants and Their Relationship With Cardio-Renal Risk Factors

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2021-12-0613

OAAI

LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206

FRONTIERS IN ONCOLOGY

IF3.3

2021-10-2218

OAAI

RETRACTION: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN (Retraction of Vol 50, Pg 178, 2019)

IF10.8

2021-10-010

OA